Advertisement
Medtronic
Subscribe to Medtronic

The Lead

Divergence System Offers New Approach to Anterior Cervical Fusion

October 21, 2014 12:02 pm | by Medtronic | News | Comments

Medtronic announced the U.S. launch of the DIVERGENCE Anterior Cervical Fusion System for the treatment of single-level cervical disc disease today at the 2014 Congress of Neurological Surgeons Annual Meeting in Boston. The DIVERGENCE System represents a new approach...

FDA Approved Leads Safe for Full-Body MRI Scans

October 15, 2014 9:46 am | by Medtronic | News | Comments

Medtronic announced the U.S. Food and Drug Administration approval of its CapSureFix Novus MRI...

Patient Monitoring Market Nears 30 Billion

October 7, 2014 9:05 am | by Kalorama Information | News | Comments

The global advanced patient monitoring market is currently worth about $29.7 billion, up 7...

$514 Billion in Global MedTech Sales by 2020

October 6, 2014 10:49 am | by Evaluate Ltd. | News | Comments

The medical technology sector is expected to grow at a compound annual growth rate of 5 percent...

View Sample

FREE Email Newsletter

Infographic: MedTech World Preview 2014

October 6, 2014 10:47 am | by Evaluate Ltd. | News | Comments

2014 marks a year of rapid change for the global medical device market, particularly within the cardiology and orthopedic spaces, which have been dominated by megamergers. If the deal between Covidien and Medtronic goes through, we could see...

MDPC Publishes Robust Security Risk Assessment Framework for Medical Devices

September 26, 2014 10:56 am | by Medical Device Privacy Consortium | News | Comments

The Medical Device Privacy Consortium's Product Security Working Group has developed a robust framework for medical device manufactures and developers to assess the security risks associated with the use of medical devices. The framework is...

CE Mark and European Launch of Medtronic’s TYRX Absorbable Antibacterial Envelope

September 22, 2014 10:33 am | by Medtronic | News | Comments

Medtronic, Inc. has received CE (Conformité Européenne) Mark for the TYRX Absorbable Antibacterial Envelope. This innovative mesh envelope covers an implantable cardiac device to help stabilize the device after implantation and reduce surgical...

Advertisement

Medtronic Launches New Balloon Kyphoplasty Products for Treating Spinal Fractures

September 17, 2014 9:55 am | by Medtronic | News | Comments

Medtronic, Inc. has announced the launch of the KYPHON Express II Balloon Kyphoplasty Platform, which includes the next generation KYPHON Cement Delivery System. This new platform is the latest advancement in the KYPHON Balloon Kyphoplasty...

Medtronic Drug-Coated Balloon for Improved Treatment of Peripheral Artery Disease

September 16, 2014 9:55 am | by Medtronic | News | Comments

Presented for the first time at the 2014 Transcatheter Cardiovascular Therapeutics (TCT) conference, the latest clinical and economic data on the IN.PACT Admiral drug-coated balloon (DCB) from Medtronic, Inc. augments an already robust body of...

Type 2 Diabetes Patients Achieve Greater Satisfaction with Insulin Pumps vs. Multiple Daily Injections

September 16, 2014 9:44 am | by Medtronic | News | Comments

Medtronic, Inc. today announced that new results from the OpT2mise trial are being presented at the European Association for the Study of Diabetes (EASD) 50th Annual Meeting. OpT2mise is the largest global study to compare insulin pump therapy...

Medtronic Launches SEEQ Wearable Cardiac Monitoring System in United States

September 15, 2014 10:18 am | by Medtronic | News | Comments

Medtronic, Inc. has announced the U.S. launch of the SEEQ Mobile Cardiac Telemetry (MCT) System, an external, wire-free, adhesive heart monitor that can be worn for up to 30 days to help detect and diagnose the cause of irregular heartbeats in...

Medtronic’s CoreValve System Sustains Positive Outcomes Through Two Years in Extreme Risk Patients

September 15, 2014 10:14 am | by Medtronic | News | Comments

Medtronic, Inc. has announced new data showing that transcatheter aortic valve replacement (TAVR) with the CoreValve System continued to provide safe and effective treatment, while maintaining exceptional rates of survival out to two years for...

Advertisement

Medtronic NC Euphora Coronary Balloon Receives FDA Clearance

September 11, 2014 9:58 am | by Medtronic | News | Comments

Medtronic, Inc. today announced the U.S. Food and Drug Administration (FDA) 510(k) clearance and launch of the NC Euphora Noncompliant Balloon Dilatation Catheter. The new device will be featured for the first time in the United States at the...

First U.S. Implants in Clinical Study of Medtronic’s Recapturable CoreValve Evolut R

September 10, 2014 9:39 am | by Medtronic | News | Comments

Medtronic, Inc. has announced the first U.S. implants in the CoreValve Evolut R Clinical Study, which will evaluate the safety and effectiveness of the new Medtronic CoreValve Evolut R System. This novel investigational self-expanding valve...

Medtronic Receives Clearance for the SHILLA Growth Guidance System

August 28, 2014 11:04 am | by Medtronic, Inc. | News | Comments

Medtronic, Inc. today announced the 510(k) clearance and launch of the SHILLA(TM) Growth Guidance System. The system is designed for treatment of skeletally immature pediatric patients less 10 years of age diagnosed with severe, progressive...

Medtronic Announces First Implants in Largest-Ever, Global Trial of Cardiac Resynchronization Therapy

August 27, 2014 12:10 pm | by The Associated Press | News | Comments

Medtronic, Inc. has announced the first implants in a clinical trial that will compare patient and healthcare system outcomes - including patient mortality and hospitalizations - in heart failure patients who have cardiac resynchronization...

Medtronic Acquires NGC Medical to Strengthen Its Integrated Health Solutions Portfolio

August 27, 2014 9:16 am | by The Associated Press | News | Comments

Medtronic, Inc. has announced that it has completed the acquisition of NGC Medical S.p.A. (NGC), a privately-held Italian company, in a transaction that values NGC at $350 million. Medtronic held a 30 percent ownership stake in the company...

Advertisement

Medtronic Acquires Sapiens Steering Brain Stimulation

August 26, 2014 12:08 pm | by Medtronic, Inc. | News | Comments

Medtronic, Inc. today announced that it has acquired Sapiens Steering Brain Stimulation (Sapiens SBS), a privately held developer of deep brain stimulation (DBS) technologies for approximately $200 million in an all-cash transaction. The...

Medtronic’s Viva Cardiac Resynchronization Therapy-Pacemaker Approved in U.S.

August 25, 2014 10:26 am | by Medtronic | News | Comments

Medtronic, Inc. has announced the U.S. Food and Drug Administration (FDA) approval of its newest cardiac resynchronization therapy-pacemaker, Viva CRT-P, for indicated patients with heart failure or atrioventricular (AV) block. The Viva CRT-P...

Tax Savings Not Only Benefit to Medtronic-Covidien Deal

August 19, 2014 10:37 am | by The Associated Press | News | Comments

US-based Medtronic said it would purchase Ireland-based Covidien for $42.9 billion, combining two of the world's biggest medical device makers and helping Medtronic savings with a headquarters change.  Kalorama estimates the deal will come...

FDA Approval for Medtronic’s Attain Performa Quadripolar Lead and Viva Quad CRT-Ds

August 7, 2014 9:47 am | by Medtronic | News | Comments

Medtronic, Inc. has announced it has received United States Food and Drug Administration (FDA) approval for the Attain Performa Model 4298 quadripolar lead, and the Viva Quad XT and Viva Quad S cardiac resynchronization therapy defibrillators...

Medtronic Launches NuVent EM Sinus Dilation System for Fusion ENT Navigation System

August 4, 2014 8:36 am | by Medtronic | News | Comments

Medtronic Inc. has announced the launch of the NuVent EM Sinus Dilation System for the Fusion ENT Navigation System, developed and manufactured by the company's Ear Nose and Throat (ENT) division of its Surgical Technologies business. NuVent...

Infographic: Insulin Pumps Beat Injections in Type 2 Diabetes Management

July 7, 2014 11:17 am | by Medtronic | News | Comments

In the OpT2mise trial, those using insulin pumps achieved a mean A1C (average blood glucose) reduction of 1.1 percent compared to only a 0.4 percent reduction by those using multiple daily injections. This improvement in glucose control was...

Type 2 Diabetes Patients Achieve Superior Outcomes with Insulin Pumps vs. Multiple Daily Injections

July 7, 2014 11:17 am | by Medtronic | News | Comments

As an example of its commitment to improving clinical outcomes for all people with diabetes, Medtronic, Inc. has announced the results of the OpT2mise trial, which showed that MiniMed insulin pumps safely achieve better glucose control for...

This Rainbow Leads to New Medical Innovations

June 27, 2014 2:45 pm | by Bloomberg | Videos | Comments

Efi Cohen-Arazi, co-founder and Chief Executive Officer at Rainbow Medical, talks with Elliott Gotkine about innovations to help those who have lost their vision and their partnership with Medtronic on a nerve stimulation product. He speaks...

Insertable Cardiac Monitors Detect Afib in Stroke Patients Better Than Standard Care

June 26, 2014 9:34 am | by Medtronic | News | Comments

Medtronic Inc. has announced results from the CRYSTAL AF (CRYptogenic STroke And underLying Atrial Fibrillation) Clinical Trial have been published in The New England Journal of Medicine. The Trial found that continuous cardiac monitoring...

GlobalData Analysts: Strategic Benefits, Not Tax Avoidance, the Main Motivation for Medtronic Megadeal

June 24, 2014 2:08 pm | by GlobalData | News | Comments

Medtronic’s $42.9 billion merger with Covidien, which created last week the world’s largest medical devices company, was primarily motivated by future market gains rather than tax inversion, according to analysts with research and consulting...

Medtronic Announces Preliminary Outcomes for World’s Smallest Cardiac Pacemaker

June 19, 2014 2:48 pm | by Medtronic | News | Comments

Medtronic, Inc. has announced preliminary results from the first human implants of the world’s smallest pacemaker, the Micra Transcatheter Pacing System (TPS). Results from the first four patients to receive the Micra TPS were reported at...

Tax Savings Not Only Benefit to Medtronic-Covidien Deal

June 18, 2014 3:53 pm | by Kalorama | News | Comments

U.S.-based Medtronic said it would purchase Ireland-based Covidien for $42.9 billion, combining two of the world’s biggest medical device makers and helping Medtronic savings with a headquarters change. Kalorama estimates the deal will come...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading